Top Markets
Coin of the day
Acepodia, Inc. Acepodia, Inc.

Acepodia, Inc.

6976
Rank in Stocks #17936
Acepodia, Inc. is an advanced-stage biotechnology firm focused on pioneering... Acepodia, Inc. is an advanced-stage biotechnology firm focused on pioneering cell-based treatments. The company utilizes its distinctive Antibody Cell Conjugation (ACC) platform technology to innovate therapeutic approaches and address critical unmet needs in oncology. Through this proprietary method, Acepodia engineers novel ACE therapies by precisely attaching tumor-specific antibodies to its specialized immune cells, such as gamma delta 2 T cells. Established in 2017, the company's corporate headquarters are situated in Grand Cayman, Cayman Islands.
Share Price
$0.37840843
Market Cap
$219.66M
Change (1 day)
-0.42%
Change (1 year)
-27.25%
Country
KY
Trade Acepodia, Inc. (6976)

Category

Number of shares outstanding for Acepodia, Inc. (6976)
Number of shares outstanding as of September 2026: 0
According to Acepodia, Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of September 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Acepodia, Inc. (6976) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
253.90M -
US
62.19M -
NL
396.00M -
US
478.91M -
AU
- -
CH